Highly specific Ο 2 R/TMEM97 ligand FEM-1689 alleviates neuropathic pain and inhibits the integrated stress response is a research paper published in Proceedings of the National Academy of Sciences (2023). On theSindex it has a DataRank of 0. It has been cited 32 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
HHS | NIH | National Institute of Neurological Disorders and Stroke
Grant: R01 NS0655926
HHS | National Institutes of Health
Grant: 1 S10 OD021508-01
Bruker AVANCE III HD 500 MHz NMR
HHS | NIH | National Institute of Mental Health
Grant: HHSN-271-2018-00023-C
Welch Foundation
Grant: F-0652
HHS | NIH | National Institute of Neurological Disorders and Stroke
Grant: R61 NS127271
HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R01 DK134893
NIH HHS
Grant: S10 OD021508
NINDS NIH HHS
Grant: UG3 NS131304
Natural Sciences and Engineering Research Council of Canada
Grant: unidentified
unidentified
National Institutes of Health
Grant: 1R01DK134893-01
Targeting methylglyoxal-induced diabetic neuropathic pain through the integrated stress response
National Institutes of Health
Grant: 1R61NS127271-01A1
Planning Study for the Development of Sigma 2 ligands as Analgesics
FWCI
3.03
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals